Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas
Authors:
Open Access
- 26 December 2009
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 36 (2) , 351-358
Abstract
Meningiomas are tumors derived from arachnoid cap cells that represent approximately 30% of all intracranial tumors. In this study, we investigated 22 human meningiomas for the expression of dipeptidyl peptidase (DPP)-IV activity and/or structure homologs (DASH), including canonical DPP-IV/CD26, fibroblast activation protein-alpha (FAPalpha), DPP8 and DPP9. DPP-IV-like enzymatic activity, including all enzymatically-active DASH molecules, was found in all 18 benign meningiomas WHO grade I and IV atypical meningiomas WHO grade II by continuous rate fluorimetric assay in tissue homogenates and catalytic enzyme histochemistry in situ. In atypical meningiomas, this activity was significantly higher and was associated with higher cell proliferation as detected by Ki67 antigen immunohistochemistry. The expression of DPP-IV/CD26 and FAPalpha demonstrated by real-time RT-PCR and immunohistochemistry was low. As shown histochemically, it occurred most often on the surface of fibrous bundles and whorls rich in extracellular matrix. Compared to DPP-IV/CD26 and FAPalpha, the expression of DPP8 and DPP9 was higher and, in addition, it was present also in the cells inside these structures. Expression of CXCR4, the receptor of pro-proliferative chemokine stromal cell-derived factor-1alpha (SDF-1alpha), DPP-IV substrate, was found in all tumors, suggesting higher values in atypical grade II samples. This is the first report on the expression status of dipeptidyl peptidase-IV and related molecules in meningiomas. It shows that DPP8 and DPP9 prevail over canonical DPP-IV/CD26 and FAPalpha in all examined patients. In addition, the study suggests an increase of DPP-IV-like enzymatic activity in these tumors of WHO grade II.Keywords
This publication has 22 references indexed in Scilit:
- Stromal cell-derived factor 1α stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and AktGynecologic Oncology, 2006
- Tissue plasminogen activator expression in meningiomas and glioblastomasClinical Neurology and Neurosurgery, 2005
- Stromal cell‐derived factor‐1α‐induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinomaInternational Journal of Cancer, 2004
- Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Expressions Correlate with the Recurrence of Intracranial MeningiomasJournal of Neuro-Oncology, 2004
- Cell-Surface Peptidases2004
- Ancient Duplications of the Human Proglucagon GeneGenomics, 2002
- Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2001
- Stromal cell‐derived factor‐1α induces astrocyte proliferation through the activation of extracellular signal‐regulated kinases 1/2 pathwayJournal of Neurochemistry, 2001
- A kinetic fluorometric assay of dipeptidyl peptidase IV in viable human blood mononuclear cellsBiochimie, 1989
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951